Interesting update on Marine Raider TAKES DOWN a Billion Dollar West-Africa Drug Op—and Barely Escapes Alive. Curious how the grades will trend next quarter.
Interesting update on Marine Raider TAKES DOWN a Billion Dollar West-Africa Drug Op—and Barely Escapes Alive. Curious how the grades will trend next quarter.
Interesting update on Marine Raider TAKES DOWN a Billion Dollar West-Africa Drug Op—and Barely Escapes Alive. Curious how the grades will trend next quarter.
Interesting update on Marine Raider TAKES DOWN a Billion Dollar West-Africa Drug Op—and Barely Escapes Alive. Curious how the grades will trend next quarter.
44 Comments
Interesting update on Marine Raider TAKES DOWN a Billion Dollar West-Africa Drug Op—and Barely Escapes Alive. Curious how the grades will trend next quarter.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Interesting update on Marine Raider TAKES DOWN a Billion Dollar West-Africa Drug Op—and Barely Escapes Alive. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Interesting update on Marine Raider TAKES DOWN a Billion Dollar West-Africa Drug Op—and Barely Escapes Alive. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Silver leverage is strong here; beta cuts both ways though.
Interesting update on Marine Raider TAKES DOWN a Billion Dollar West-Africa Drug Op—and Barely Escapes Alive. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Production mix shifting toward Videos might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Production mix shifting toward Videos might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.